SPDYE5
gene geneOn this page
Summary
SPDYE5 (speedy/RINGO cell cycle regulator family member E5, HGNC:35464) is a protein-coding gene on chromosome 7q11.23, encoding Speedy protein E5 (A6NIY4). It is a selective cancer dependency (DepMap: 60.0% of cell lines).
Predicted to enable protein kinase binding activity. Predicted to be involved in positive regulation of cyclin-dependent protein serine/threonine kinase activity.
Source: NCBI Gene 442590 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 92 total
- Cancer dependency (DepMap): dependent in 60.0% of screened cell lines
- MANE Select transcript:
NM_001306141
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:35464 |
| Approved symbol | SPDYE5 |
| Name | speedy/RINGO cell cycle regulator family member E5 |
| Location | 7q11.23 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000170092 |
| Ensembl biotype | protein_coding |
| Entrez | 442590 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000625065
RefSeq mRNA: 1 — MANE Select: NM_001306141
NM_001306141
CCDS: CCDS78241
Canonical transcript exons
ENST00000625065 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001599218 | 75501362 | 75501755 |
| ENSE00002439498 | 75495156 | 75495374 |
| ENSE00003533963 | 75499231 | 75499316 |
| ENSE00003679008 | 75497938 | 75497996 |
| ENSE00003758563 | 75493627 | 75494207 |
| ENSE00003758807 | 75502833 | 75504316 |
| ENSE00003759401 | 75496674 | 75496904 |
| ENSE00003759910 | 75501878 | 75501982 |
| ENSE00003937692 | 75492320 | 75492441 |
Expression profiles
Bgee: expression breadth ubiquitous, 133 present calls, max score 81.05.
Top tissues by expression
133 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 81.05 | gold quality |
| sural nerve | UBERON:0015488 | 76.32 | gold quality |
| bone marrow cell | CL:0002092 | 73.93 | silver quality |
| stromal cell of endometrium | CL:0002255 | 70.55 | gold quality |
| tonsil | UBERON:0002372 | 69.20 | gold quality |
| bone marrow | UBERON:0002371 | 67.29 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 67.16 | gold quality |
| colonic epithelium | UBERON:0000397 | 67.01 | silver quality |
| blood | UBERON:0000178 | 65.26 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 65.07 | gold quality |
| testis | UBERON:0000473 | 64.23 | gold quality |
| liver | UBERON:0002107 | 63.93 | gold quality |
| cortical plate | UBERON:0005343 | 63.77 | gold quality |
| left testis | UBERON:0004533 | 63.64 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 63.16 | gold quality |
| right testis | UBERON:0004534 | 63.14 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 63.08 | gold quality |
| ventricular zone | UBERON:0003053 | 62.96 | gold quality |
| uterine cervix | UBERON:0000002 | 62.84 | gold quality |
| urinary bladder | UBERON:0001255 | 62.69 | gold quality |
| thyroid gland | UBERON:0002046 | 62.30 | gold quality |
| adrenal tissue | UBERON:0018303 | 62.18 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 62.15 | gold quality |
| spleen | UBERON:0002106 | 62.11 | gold quality |
| cortex of kidney | UBERON:0001225 | 61.71 | gold quality |
| primary visual cortex | UBERON:0002436 | 61.70 | gold quality |
| right lobe of liver | UBERON:0001114 | 61.61 | gold quality |
| calcaneal tendon | UBERON:0003701 | 61.58 | gold quality |
| myometrium | UBERON:0001296 | 61.47 | gold quality |
| zone of skin | UBERON:0000014 | 61.36 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.33 |
Regulation
Is transcription factor: no
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 60.0% of screened cell lines.
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Spdye4b | ENSMUSG00000029586 |
| mus_musculus | Spdye4a | ENSMUSG00000039296 |
| rattus_norvegicus | Spdye4 | ENSRNOG00000058563 |
Paralogs (18): SPDYE1 (ENSG00000136206), SPDYE2B (ENSG00000173678), SPDYE4 (ENSG00000183318), SPDYE12 (ENSG00000184616), SPDYE16 (ENSG00000185040), SPDYE17 (ENSG00000186645), SPDYE2 (ENSG00000205238), SPDYE18 (ENSG00000205482), SPDYE3 (ENSG00000214300), SPDYE21 (ENSG00000230358), SPDYE6 (ENSG00000260097), SPDYE9 (ENSG00000262461), SPDYE8 (ENSG00000273520), SPDYE10 (ENSG00000274570), SPDYE11 (ENSG00000275976), SPDYE15 (ENSG00000286014), SPDYE13 (ENSG00000286038), SPDYE14 (ENSG00000286137)
Protein
Protein identifiers
Speedy protein E5 — A6NIY4 (reviewed: A6NIY4)
All UniProt accessions (1): A6NIY4
UniProt curated annotations — full annotation on UniProt →
Similarity. Belongs to the Speedy/Ringo family.
RefSeq proteins (1): NP_001293070* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR020984 | Speedy | Family |
| IPR057742 | Speedy_E | Family |
Pfam: PF11357
UniProt features (4 total): compositionally biased region 2, chain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A6NIY4-F1 | 60.45 | 0.20 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 32 (showing top):
chr7q11, GOMF_KINASE_BINDING, MIR153_5P, MIR3662, MIR607, MIR1277_5P, MIR95_5P, MIR3121_3P, MIR1297, MIR26A_5P, MIR26B_5P, MIR545_3P, MIR3924, MIR4465, MIR410_3P
GO Biological Process (1): positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737)
GO Molecular Function (1): protein kinase binding (GO:0019901)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of cyclin-dependent protein serine/threonine kinase activity | 1 |
| cyclin-dependent protein serine/threonine kinase activity | 1 |
| positive regulation of cell cycle | 1 |
| positive regulation of protein serine/threonine kinase activity | 1 |
| positive regulation of cyclin-dependent protein kinase activity | 1 |
| kinase binding | 1 |
Protein interactions and networks
STRING
42 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SPDYE5 | LRRC37A | A6NMS7 | 610 |
| SPDYE5 | LRRC37A3 | O60309 | 608 |
| SPDYE5 | GOLGA6L10 | A6NI86 | 507 |
| SPDYE5 | NBPF9 | P0DPF3 | 479 |
| SPDYE5 | NBPF11 | Q86T75 | 446 |
| SPDYE5 | NBPF14 | Q5TI25 | 446 |
| SPDYE5 | NBPF15 | Q8N660 | 418 |
| SPDYE5 | NOTCH2NLB | P0DPK3 | 308 |
| SPDYE5 | LINS1 | Q8NG48 | 290 |
| SPDYE5 | NBPF10 | Q6P3W6 | 271 |
| SPDYE5 | RHCE | P18577 | 249 |
| SPDYE5 | PRDM9 | Q9NQV7 | 213 |
| SPDYE5 | SPDYE1 | Q8NFV5 | 0 |
| SPDYE5 | CDK2 | P24941 | 0 |
| SPDYE5 | CDC25C | P30307 | 0 |
| SPDYE5 | SPDYA | Q5MJ70 | 0 |
| SPDYE5 | SPDYC | Q5MJ68 | 0 |
| SPDYE5 | CDK1 | P06493 | 0 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A0J9YY54, A0A494C086, A0A494C0Z2, A0A494C191, A6NHP3, A6NIY4, A6NJR5, A6NNV3, B4DH59, F6SZT2, P0C6Y7, P0CI01, P0DKJ7, P0DKJ8, P0DTA3, P0DUD1, P0DUD2, P0DUD3, P0DUD4, P0DUX0, P0DUX1, P0DV79, P79386, Q08AG5, Q13342, Q16666, Q3BBV2, Q495Y8, Q587J8, Q5JRC9, Q5QGU6, Q5RD14, Q5RKG3, Q63HK3, Q6ITT4, Q7TQI8, Q86T75, Q8IWY8, Q8N660, Q8NFV5
Diamond homologs: A0A494C086, A0A494C0Z2, A0A494C191, A6NHP3, A6NIY4, A6NJR5, A6NKU9, A6NLX3, A6NNV3, P0CI01, P0DTA3, P0DUD1, P0DUD2, P0DUD3, P0DUD4, P0DUX0, P0DUX1, P0DV79, Q495Y7, Q495Y8, Q5IBH6, Q5IBH7, Q5MJ68, Q5MJ70, Q8NFV5, Q8R496, Q9PU13, Q9YGL1
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
92 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 77 |
| Likely benign | 6 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
900 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 7:75494189:G:GT | donor_gain | 1.0000 |
| 7:75501360:A:AG | acceptor_gain | 1.0000 |
| 7:75501361:G:GG | acceptor_gain | 1.0000 |
| 7:75501752:GGAG:G | donor_gain | 1.0000 |
| 7:75501753:GAGG:G | donor_gain | 1.0000 |
| 7:75501754:AGG:A | donor_loss | 1.0000 |
| 7:75501757:T:G | donor_loss | 1.0000 |
| 7:75494174:G:GT | donor_gain | 0.9900 |
| 7:75494178:T:TA | donor_gain | 0.9900 |
| 7:75494179:G:GA | donor_gain | 0.9900 |
| 7:75494205:CAG:C | donor_loss | 0.9900 |
| 7:75494207:GGTGA:G | donor_loss | 0.9900 |
| 7:75494208:G:GA | donor_loss | 0.9900 |
| 7:75494209:T:A | donor_loss | 0.9900 |
| 7:75497936:A:AG | acceptor_gain | 0.9900 |
| 7:75497937:G:GG | acceptor_gain | 0.9900 |
| 7:75499317:G:GG | donor_gain | 0.9900 |
| 7:75501356:CCTCA:C | acceptor_loss | 0.9900 |
| 7:75501357:CTCAG:C | acceptor_loss | 0.9900 |
| 7:75501358:TCA:T | acceptor_loss | 0.9900 |
| 7:75501360:AG:A | acceptor_loss | 0.9900 |
| 7:75501361:G:GA | acceptor_loss | 0.9900 |
| 7:75501361:GCT:G | acceptor_gain | 0.9900 |
| 7:75501361:GCTA:G | acceptor_gain | 0.9900 |
| 7:75501361:GCTAC:G | acceptor_gain | 0.9900 |
| 7:75501431:G:GT | donor_gain | 0.9900 |
| 7:75496897:GCTGC:G | donor_gain | 0.9800 |
| 7:75496956:G:GT | donor_gain | 0.9800 |
| 7:75496957:A:T | donor_gain | 0.9800 |
| 7:75497935:CAG:C | acceptor_gain | 0.9800 |
AlphaMissense
2655 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 7:75497958:T:C | F211L | 0.990 |
| 7:75497960:C:A | F211L | 0.990 |
| 7:75497960:C:G | F211L | 0.990 |
| 7:75496889:T:C | F199L | 0.986 |
| 7:75496891:C:A | F199L | 0.986 |
| 7:75496891:C:G | F199L | 0.986 |
| 7:75501404:A:C | K266N | 0.983 |
| 7:75501404:A:T | K266N | 0.983 |
| 7:75499258:T:C | F233L | 0.979 |
| 7:75499260:C:A | F233L | 0.979 |
| 7:75499260:C:G | F233L | 0.979 |
| 7:75497959:T:C | F211S | 0.977 |
| 7:75499306:T:C | F249L | 0.975 |
| 7:75499308:C:A | F249L | 0.975 |
| 7:75499308:C:G | F249L | 0.975 |
| 7:75497971:A:C | D215A | 0.969 |
| 7:75497971:A:T | D215V | 0.967 |
| 7:75497992:A:T | D222V | 0.959 |
| 7:75496890:T:C | F199S | 0.958 |
| 7:75501420:T:C | F272L | 0.958 |
| 7:75501422:C:A | F272L | 0.958 |
| 7:75501422:C:G | F272L | 0.958 |
| 7:75501403:A:T | K266I | 0.955 |
| 7:75497970:G:C | D215H | 0.953 |
| 7:75499235:T:C | L225P | 0.951 |
| 7:75499259:T:C | F233S | 0.950 |
| 7:75499255:T:G | Y232D | 0.946 |
| 7:75499303:T:C | F248L | 0.946 |
| 7:75499305:C:A | F248L | 0.946 |
| 7:75499305:C:G | F248L | 0.946 |
dbSNP variants (sampled 300 via entrez): RS10230587 (7:75494283 C>A,T), RS10274653 (7:75491667 C>G,T), RS10441325 (7:75494456 C>A,G,T), RS1062117 (7:75493577 G>A,C), RS111295044 (7:75494029 C>A), RS112356339 (7:75495039 A>G), RS112531644 (7:75491716 T>G), RS112606868 (7:75490582 G>A,C), RS112624224 (7:75490107 C>T), RS112778680 (7:75502906 G>A), RS113247842 (7:75498758 G>A,T), RS113429735 (7:75495770 T>A,C), RS113743614 (7:75494937 A>G), RS113790339 (7:75490861 G>A), RS113959810 (7:75504494 T>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST008361_9 | Response to cognitive-behavioural therapy in major depressive disorder | 6.000000e-06 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007820 | cognitive behavioural therapy |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| pentanal | decreases expression | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| Cadmium | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Lactic Acid | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.